ELICIO THERAPEUTICS, INC.
Profile
Company Names
ELICIO THERAPEUTICS, INC.
VEDANTRA PHARMACEUTICALS, INC.
Addresses
451 D STREET, 5TH FLOOR, SUITE 501, BOSTON, MA 02210
ONE KENDALL SQUARE, BUILDING 1400 WEST, SUITE 14303, CAMBRIDGE, MA 02139
ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA 02142
Phone Numbers
857-209-0050
617-360-9995
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2011
State Incorporated:
DELAWARE
Total Amount Raised:
$105,312,570.00
Number of Funding Rounds:
10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2022-05-12
$21,995,420.00
$50,000,000.00
$28,004,580.00
Equity
9
2021-10-04
$14,470,000.00
$15,000,000.00
$530,000.00
Debt
8
2020-06-30
$6,085,000.00
$30,000,000.00
$23,915,000.00
Equity
7
2020-02-27
$8,411,801.00
$8,411,801.00
$0.00
Equity
6
2019-09-30
$7,000,000.00
$7,000,000.00
$0.00
Equity
5
2018-08-30
$25,817,848.00
$36,235,347.00
$10,417,499.00
Equity
4
2018-07-20
$14,492,501.00
$14,492,501.00
$0.00
Debt
3
2018-05-21
$2,990,000.00
$3,000,000.00
$10,000.00
Debt
2
2016-05-16
$750,000.00
$1,500,000.00
$750,000.00
Equity, Debt
1
2012-07-18
$3,300,000.00
$5,000,000.00
$1,700,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JULIAN
ADAMS
DIRECTOR, EXECUTIVE OFFICER
DANIEL
BEHR
DIRECTOR
ISAAC
BLECH
DIRECTOR
SOCIALWISE, INC. (FORMERLY KNOWN AS IDEAEDGE, INC)
| CONTRAFECT CORP
| BILLMYPARENTS, INC.
| CERECOR INC.
| MEDGENICS, INC.
| PREMIER ALLIANCE GROUP, INC.
| EDGE THERAPEUTICS, INC.
| SPENDSMART PAYMENTS CO
| CENTREXION CORP
| RESTORGENEX CORP
| ROOT9B TECHNOLOGIES INC.
| WAVEGUIDE CORP
| X4 PHARMACEUTICALS, INC.
| ROOT9B TECHNOLOGIES, INC.
| INSPIREMD, INC.
| CENTREXION THERAPEUTICS CORP
| SAPIENCE THERAPEUTICS, INC.
| ARIDIS PHARMACEUTICALS, INC.
| X-VAX TECHNOLOGY, INC.
| REGENOVATION, INC.
| DIFFUSION PHARMACEUTICALS INC.
| NACUITY PHARMACEUTICALS, INC.
| ELUCIDA ONCOLOGY, INC.
| MARINA BIOTECH, INC.
| ALVEO TECHNOLOGIES INC.
| VEDANTRA PHARMACEUTICALS, INC.
BEN
BRONSTEIN
DIRECTOR
YEKATERINA
CHUDNOVSKY
DIRECTOR
ROBERT
CONNELLY
EXECUTIVE OFFICER, DIRECTOR
DANIEL
GEFFKEN
EXECUTIVE OFFICER, DIRECTOR
SYNLOGIC, INC.
| LYSOSOMAL THERAPEUTICS, INC.
| OPSONIX, INC.
| APELLIS PHARMACEUTICALS, INC.
| ARCTURUS THERAPEUTICS LTD.
| VEDANTRA PHARMACEUTICALS, INC.
| SG DAN HOLDINGS LLC
| ELICIO THERAPEUTICS, INC.
| WINDTREE THERAPEUTICS INC /DE/
| PROMIS NEUROSCIENCES INC.
| CALCIMEDICA SUBSIDIARY, INC.
| CALCIMEDICA, INC.
CHRISTOPHER
HAQQ
EXECUTIVE OFFICER
ISAAC
KOHLBERG
DIRECTOR
WILLIAM
KOSTER
DIRECTOR
ROBERT
RUFFOLO
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-05-12
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-05-12
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2021-10-04
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2021-10-04
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2021-10-04

